Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Bieschke

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 15, 2013
Natural compounds may open new routes to treatment of amyloid diseasesJan Bieschke
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
Catch, dock, unravel, and lockJan Bieschke
Advances in Experimental Medicine and Biology|June 21, 2015
The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common MechanismKathrin Andrich, Jan Bieschke
Physical Chemistry Chemical Physics : PCCP|July 4, 2017
Glucose directs amyloid-beta into membrane-active oligomersNiraja Kedia, Michael Almisry, Jan Bieschke
Biomolecules|November 24, 2022
Essential Components of Synthetic Infectious Prion Formation De NovoKezia Jack, Graham S Jackson, Jan Bieschke
Journal of the American Chemical Society|November 3, 2005
E-olefin dipeptide isostere incorporation into a polypeptide backbone enables hydrogen bond perturbation: probing the requirements for Alzheimer's amyloidogenesisYanwen Fu, Jan Bieschke, Jeffery W Kelly
Biotechniques|July 10, 2013
Counting unstained, confluent cells by modified bright-field microscopyL Louis Drey, Michael C Graber, Jan Bieschke
Biochemistry|February 7, 2007
The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formationSarah J Siegel, Jan Bieschke, Evan T Powers, et al.
Biochemistry|December 15, 2007
Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?Jan Bieschke, Sarah J Siegel, Yanwen Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2004
Autocatalytic self-propagation of misfolded prion proteinJan Bieschke, Petra Weber, Nikolaus Sarafoff, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 15, 2013
Natural compounds may open new routes to treatment of amyloid diseasesJan Bieschke
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
Catch, dock, unravel, and lockJan Bieschke
Advances in Experimental Medicine and Biology|June 21, 2015
The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common MechanismKathrin Andrich, Jan Bieschke
Physical Chemistry Chemical Physics : PCCP|July 4, 2017
Glucose directs amyloid-beta into membrane-active oligomersNiraja Kedia, Michael Almisry, Jan Bieschke
Biomolecules|November 24, 2022
Essential Components of Synthetic Infectious Prion Formation De NovoKezia Jack, Graham S Jackson, Jan Bieschke
Journal of the American Chemical Society|November 3, 2005
E-olefin dipeptide isostere incorporation into a polypeptide backbone enables hydrogen bond perturbation: probing the requirements for Alzheimer's amyloidogenesisYanwen Fu, Jan Bieschke, Jeffery W Kelly
Biotechniques|July 10, 2013
Counting unstained, confluent cells by modified bright-field microscopyL Louis Drey, Michael C Graber, Jan Bieschke
Biochemistry|February 7, 2007
The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formationSarah J Siegel, Jan Bieschke, Evan T Powers, et al.
Biochemistry|December 15, 2007
Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?Jan Bieschke, Sarah J Siegel, Yanwen Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2004
Autocatalytic self-propagation of misfolded prion proteinJan Bieschke, Petra Weber, Nikolaus Sarafoff, et al.
Pageof 5